valuation model, page-8

Hi Worthind

I am sick and tired of hearing how good ATC is. What really is the commercial good of it? Especially if a competitor gets fast tracked approval for an AIDS drug. I am thinking again of dumping Avexa shares. The half year report seems to confirm this is a bottomless pit into which hopefulls throw money. Net tangible value per share down and obviously funded by SPP after SPP. Lets hear something about how they are going to get value for shareholders and not go the way of Ventracor, the Australian artificial heart maker who went bust. The last thing I want, like a lot of others, is do my dough like I did with Ventracor.